UMB Bank’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61K Buy
201
+79
+65% +$1.1K ﹤0.01% 2136
2026
Q1
$1.15K Sell
122
-313
-72% -$3.44K ﹤0.01% 2207
2025
Q4
$5.4K Buy
435
+126
+41% +$1.68K ﹤0.01% 1999
2025
Q3
$4.43K Buy
309
+57
+23% +$781 ﹤0.01% 1910
2025
Q2
$3.09K Sell
252
-273
-52% -$3.96K ﹤0.01% 1937
2025
Q1
$11.5K Buy
525
+119
+29% +$2.8K ﹤0.01% 1499
2024
Q4
$9.21K Buy
406
+2
+0.5% +$44 ﹤0.01% 1496
2024
Q3
$7.34K Buy
404
+329
+439% +$7.63K ﹤0.01% 1598
2024
Q2
$2.19K Buy
75
+33
+79% +$979 ﹤0.01% 1744
2024
Q1
$1.49K Sell
42
-81
-66% -$3.24K ﹤0.01% 1625
2023
Q4
$5.36K Hold
123
﹤0.01% 1398
2023
Q3
$4.7K Sell
123
-604
-83% -$25.4K ﹤0.01% 1430
2023
Q2
$29.9K Sell
727
-133
-15% -$6.4K ﹤0.01% 978
2023
Q1
$49.4K Hold
860
﹤0.01% 842
2022
Q4
$48K Hold
860
﹤0.01% 860
2022
Q3
$36K Sell
860
-4
-0.5% -$205 ﹤0.01% 949
2022
Q2
$47K Sell
864
-17
-2% -$1.02K ﹤0.01% 935
2022
Q1
$57K Sell
881
-153
-15% -$10.1K ﹤0.01% 935
2021
Q4
$69K Buy
+1,034
New +$70K ﹤0.01% 897

Other funds holding IART

UMB Bank's IART Position: Q2 2026 in Review

UMB Bank increased its Integra LifeSciences (IART) stake by 65% in Q2 2026, buying an estimated $1.1K and bringing the position to 201 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2136.

UMB Bank first reported a position in IART in Q4 2021 and has held it in 19 quarters since. The position peaked at $69K in Q4 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • UMB Bank held 201 shares of Integra LifeSciences worth $3.61K as of Q2 2026.
  • UMB Bank bought 79 Integra LifeSciences shares in Q2 2026, an estimated $1.1K.
  • Integra LifeSciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2136 holding.
  • UMB Bank first reported a position in Integra LifeSciences in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Integra LifeSciences position peaked at $69K in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.